The Hormonal Driver: Androgen-Responsive Genes in Prostate Cancer
Prostate cancer is entirely addicted to testosterone. If you cut off the androgen supply, the tumor violently crashes into apoptosis. However, the cancer inevitably mutates, learning to survive without the hormone, leading to lethal, castration-resistant disease. Androgen-Responsive Genes in Prostate Cancer is a brutally deep, fiercely specialized genetic manual detailing exactly how this resistance occurs. This volume provides the precise molecular blueprints for targeting the androgen receptor.
Mastering the Receptor Mutagenesis
The core philosophy of this text is the inevitability of acquired resistance. The authors aggressively detail the biology of the Androgen Receptor (AR). It dictates exactly how the tumor cell amplifies the AR gene or creates truncated “splice variants” (like AR-V7) that remain permanently turned “on” even when testosterone levels in the blood are absolutely zero.
Navigating the Next-Generation Inhibitor
The book provides a masterclass in overcoming hormonal resistance. It dictates the exact pharmacological pathways for next-generation antiandrogens. It rigorously covers how drugs like Enzalutamide were specifically engineered to physically block the androgen receptor from entering the nucleus, entirely shutting down the genetic transcription that drives the cancer’s survival.
Frequently Asked Questions (FAQs)
Does this book cover surgical removal of the prostate (prostatectomy)?
No, its absolute, exclusive focus is on the *molecular genetics, endocrinology, and pharmacology* of the androgen receptor and its role in cancer progression.
Who is the primary audience?
It is the absolute, mandatory definitive reference for Prostate Cancer Researchers, Urologic Oncologists, and Molecular Biologists.
